DAA2194 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
frontal lobe |
Human |
C1QA |
98.4% Increase Gene Expression Level |
|
DAA2289 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
105.3% Increase Gene Expression Level |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
32.2% Increase Gene Expression Level |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2195 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
frontal lobe |
Human |
C1QB |
166.8% Increase Gene Expression Level |
|
DAA1078 |
Pipecolic Acid Oxidase |
Molecular |
frontal lobe |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA2293 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
52.1% Increase Gene Expression Level |
|
DAA1102 |
Myogenic Differentiation 1 |
Molecular |
frontal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1082 |
Dipeptidyl-peptidase 8 |
Molecular |
frontal lobe |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA2290 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
111.4% Increase Gene Expression Level |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
Molecular |
frontal lobe |
Human |
FCGRT |
89.3% Increase Gene Expression Level |
|
DAA2351 |
Pannexin 2 decreases with age |
Molecular |
frontal lobe |
Human |
PANX2 |
8.1% Decrease Gene Expression Level |
|
DAA2345 |
major histocompatibility complex, class I, E increases with age |
Molecular |
frontal lobe |
Human |
HLA-E |
65.7% Increase Gene Expression Level |
|
DAA2370 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB1 |
84.8% Increase Gene Expression Level |
|
DAA2244 |
S100 calcium binding protein A9 increases with age |
Molecular |
frontal lobe |
Human |
S100A9 |
92.8% Increase Gene Expression Level |
|
DAA2162 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
261.1% Increase Gene Expression Level |
|
DAA2198 |
complement component 3a receptor 1 increases with age |
Molecular |
frontal lobe |
Human |
C3AR1 |
89.0% Increase Gene Expression Level |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2154 |
complement component 4B increases with age |
Molecular |
frontal lobe |
Human |
C4B |
895.9% Increase Gene Expression Level |
|
DAA1114 |
Growth Arrest-specific 2 Like 3 |
Molecular |
frontal lobe |
Human |
GAS2L3 |
Increase DNA Methylation |
|
DAA2236 |
CD14 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD14 |
134.9% Increase Gene Expression Level |
|
DAA2199 |
complement component 5 increases with age |
Molecular |
frontal lobe |
Human |
C5 |
43.7% Increase Gene Expression Level |
|
DAA2382 |
major histocompatibility complex, class I, C increases with age |
Molecular |
frontal lobe |
Human |
HLA-C |
44.0% Increase Gene Expression Level |
|
DAA2153 |
complement component 4A increases with age |
Molecular |
frontal lobe |
Human |
C4A |
187.3% Increase Gene Expression Level |
|
DAA2246 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
250.2% Increase Gene Expression Level |
|